Cargando…

Restoration of foveal photoreceptors after intravitreal ranibizumab injections for diabetic macular edema

Anti-vascular endothelial growth factor drugs are the first-line treatment for diabetic macular edema (DME), although the mechanism of the visual acuity (VA) improvement remains largely unknown. The association between photoreceptor damage and visual impairment encouraged us to retrospectively inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Yuki, Suzuma, Kiyoshi, Uji, Akihito, Ishihara, Kenji, Yoshitake, Shin, Fujimoto, Masahiro, Dodo, Yoko, Yoshitake, Tatsuya, Miwa, Yuko, Murakami, Tomoaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155247/ https://www.ncbi.nlm.nih.gov/pubmed/27966644 http://dx.doi.org/10.1038/srep39161

Ejemplares similares

Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab
por: Yoshitake, Tatsuya, et al.
Publicado: (2019)

Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema
por: Mori, Yuki, et al.
Publicado: (2017)

Hyperreflective Foci in the Outer Retinal Layers as a Predictor of the Functional Efficacy of Ranibizumab for Diabetic Macular Edema
por: Yoshitake, Tatsuya, et al.
Publicado: (2020)

Anti-Hexokinase 1 Antibody as a Novel Serum Biomarker of a Subgroup of Diabetic Macular Edema
por: Yoshitake, Tatsuya, et al.
Publicado: (2019)

Clinical relevance of reduced decorrelation signals in the diabetic inner choroid on optical coherence tomography angiography
por: Dodo, Yoko, et al.
Publicado: (2017)

Hyperreflective Walls in Foveal Cystoid Spaces as a Biomarker of Diabetic Macular Edema Refractory to Anti-VEGF Treatment
por: Terada, Noriko, et al.
Publicado: (2020)

Relationship between Functional and Structural Changes in Diabetic Vessels in Optical Coherence Tomography Angiography
por: Miwa, Yuko, et al.
Publicado: (2016)

In Vivo Choroidal Vascular Lesions in Diabetes on Swept-Source Optical Coherence Tomography
por: Murakami, Tomoaki, et al.
Publicado: (2016)

Clinical Relevance of Parafoveal Intercapillary Spaces and Foveal Avascular Zone in Diabetic Retinopathy Without Macular Edema
por: Terada, Noriko, et al.
Publicado: (2022)

Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
por: Shimizu, Norihiro, et al.
Publicado: (2017)

Foveal Damage Due to Subfoveal Hemorrhage Associated with Branch Retinal Vein Occlusion
por: Muraoka, Yuki, et al.
Publicado: (2015)

Decorrelation Signal of Diabetic Hyperreflective Foci on Optical Coherence Tomography Angiography
por: Murakami, Tomoaki, et al.
Publicado: (2018)

White Dots as a Novel Marker of Diabetic Retinopathy Severity in Ultrawide Field Imaging
por: Dodo, Yoko, et al.
Publicado: (2016)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
por: Kim, Moosang, et al.
Publicado: (2013)

Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab
por: Menezes, Carlos, et al.
Publicado: (2015)

Intravitreal Ranibizumab Versus Intravitreal Ranibizumab Combined with Posterior Subtenon Triamcinolone Acetonide in Diabetic Macular Edema
por: Karatas, Gamze, et al.
Publicado: (2021)

Association between retinal hemorrhagic pattern and macular perfusion status in eyes with acute branch retinal vein occlusion
por: Muraoka, Yuki, et al.
Publicado: (2016)

Potential Measurement Errors Due to Image Enlargement in Optical Coherence Tomography Imaging
por: Uji, Akihito, et al.
Publicado: (2015)

Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
por: Demircan, Ali, et al.
Publicado: (2018)

Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment
por: Kaya, Mahmut, et al.
Publicado: (2018)

Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
por: Minami, Yoshiro, et al.
Publicado: (2017)

Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
por: Gabr, Ahmed F., et al.
Publicado: (2023)

Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
por: Chiu, Chiung-Yi, et al.
Publicado: (2021)

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant
por: Herbaut, Antoine, et al.
Publicado: (2017)

Comparison of Intravitreal Dexamethasone Implant and Ranibizumab in Vitrectomized Eyes with Diabetic Macular Edema
por: Wang, Jia-Kang, et al.
Publicado: (2021)

Multifocal Electroretinogram Alterations after Intravitreal Ranibizumab Treatment in Diabetic Macular Edema
por: Kaderli, Sema Tamer, et al.
Publicado: (2022)

Efficacy of intravitreal dexamethasone implant in persistent diabetic macular edema after primary treatment with intravitreal ranibizumab
por: Özata, Kübra, et al.
Publicado: (2019)

Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema
por: Shiraya, Tomoyasu, et al.
Publicado: (2017)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
por: Pessoa, Bernardete, et al.
Publicado: (2021)

Analysis of cytokines in the aqueous humor during intravitreal Ranibizumab treatment of diabetic macular edema
por: de Freitas, Luiz Guilherme Azevedo, et al.
Publicado: (2021)

Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis
por: Sun, Xiaolei, et al.
Publicado: (2020)

Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion
por: Liang, Xuemei, et al.
Publicado: (2022)

Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration
por: Rishi, Pukhraj, et al.
Publicado: (2011)

Foveal threshold and photoreceptor integrity for prediction of visual acuity after intravitreal aflibercept on age-related macular degeneration
por: Sakai, Tsutomu, et al.
Publicado: (2018)

Foveal eversion patterns in diabetic macular edema
por: Arrigo, Alessandro, et al.
Publicado: (2022)

Intravitreal corticosteroid implant vs intravitreal ranibizumab for the treatment of macular edema: a meta-analysis of randomized controlled trials
por: Wei, Qingquan, et al.
Publicado: (2019)

The Application of Structural Retinal Biomarkers to Evaluate the Effect of Intravitreal Ranibizumab and Dexamethasone Intravitreal Implant on Treatment of Diabetic Macular Edema
por: Ceravolo, Ida, et al.
Publicado: (2020)

Intravitreal Injection of Dexamethasone Implant and Ranibizumab in Cystoid Macular Edema in the Course of Irvine-Gass Syndrome
por: Fenicia, Vito, et al.
Publicado: (2014)

Comparative Evaluation of Combined Navigated Laser Photocoagulation and Intravitreal Ranibizumab in the Treatment of Diabetic Macular Edema
por: Liegl, Raffael, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l107kfahi8enqn20i4tbdom5sj